Shares of SalvaRx Group Plc (LON:SALV) hit a new 52-week low on Friday . The stock traded as low as GBX 10 ($0.13) and last traded at GBX 12.50 ($0.16), with a volume of 34000 shares traded. The stock had previously closed at GBX 12.50 ($0.16).
Separately, Northland Securities reissued a “corporate” rating on shares of SalvaRx Group in a report on Tuesday, December 11th.
The firm has a market capitalization of $4.59 million and a price-to-earnings ratio of -1.79.
About SalvaRx Group (LON:SALV)
SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.
Featured Story: What is the S&P 500 Index?
Receive News & Ratings for SalvaRx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SalvaRx Group and related companies with MarketBeat.com's FREE daily email newsletter.